Thanks to visit codestin.com
Credit goes to www.scribd.com

Scribd
Upload
22 views1 page

Navraj Singh-Male30 Years-533118

The report details the clinical biochemistry results for Mr. Navraj Singh, a 30-year-old male, with a glycosylated hemoglobin (HbA1c) level of 5.6%, indicating non-diabetic status. The estimated average glucose is 114.02 mg/dL, which falls within the normal range. The report emphasizes the importance of correlating assay results with clinical findings and monitoring for diabetic patients based on HbA1c levels.

Uploaded by

Navraj
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
22 views1 page

Navraj Singh-Male30 Years-533118

The report details the clinical biochemistry results for Mr. Navraj Singh, a 30-year-old male, with a glycosylated hemoglobin (HbA1c) level of 5.6%, indicating non-diabetic status. The estimated average glucose is 114.02 mg/dL, which falls within the normal range. The report emphasizes the importance of correlating assay results with clinical findings and monitoring for diabetic patients based on HbA1c levels.

Uploaded by

Navraj
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Name : MR.

NAVRAJ SINGH
Age/Gender : 30 years / Male Ref. Doctor : VAISHALI YEOLE MBBS DGO MEDID : 503711
Sample Type : WB EDTA Collected : Feb 19, 2025, 10:44 a.m.
Sample ID : 243445657 Received : Feb 19, 2025, 12:52 p.m.
Client Name : 2MHNAG037 Reported : Feb 19, 2025, 01:20 p.m.

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Glycosylated Hemoglobin (GHb/HBA1c)


HbA1c 5.6 % < 6.0 : Non Diabetic
(Method: HPLC)
6.1 – 6.5 : Prediabetic
6.6 – 7.0 : Good Control
7.1-8.0 : POOR Control
>8.1 : ALERT
Estimated Average Glucose (eAG) 114.02 % 70 - 136
Interpretation:
Excellent Control: 6 to 7 %

Fair to Good Control: 7 to 8 %

Unsatisfactory Control: 8 to 10 %

and Poor Control: More than 10%.

Factors Influencing HbA1c Results: Increased levels: Elevated fetal hemoglobin, chronic renal failure, iron deficiency anemia, splenectomy,

heightened serum triglycerides, alcohol consumption, poisoning (Lead, Opiate), and salicylate therapy. Decreased levels: are often associated with

systemic inflammatory diseases and reduced RBC life span, severe iron deficiency & haemolytic anaemia, chronic renal failure, and liver diseases.

Clinical correlation reduced red blood cell lifespan (such as in hemolytic anemia or blood loss), following blood transfusions, during pregnancy, excessive

intake of Vitamin E or Vitamin C, and hemoglobinopathies, For HbF > 25% and homozygous hemoglobinopathy, an alternate platform (Fructosamine) is

recommended for testing of HbA1c.

• HbA1c, also known as glycosylated hemoglobin or glycated hemoglobin, refers to hemoglobin that has glucose molecules attached. It gives an

average of glucose levels in the bloodstream for the preceding 2 to 3 months.

• HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines for the diagnosis of diabetes using a cut-off point of

6.5%.

• For diabetic patients achieving treatment objectives, the HbA1c test should be conducted at least biannually. If treatment objectives are not met or if

a new regimen is initiated, testing once every 3 months is recommended.

• The HbA1c target for non-pregnant adults is generally set at below 7% to prevent microvascular complications.

• In known diabetic patients, the following values can be considered as a tool for monitoring glycemic control.

Associated tests: HOMA IR index, insulin, C-peptide levels.

**END OF REPORT**

This is an electronically authenticated report. Report Printed Date: Feb 19, 2025, 02:36 p.m.
NOTE: Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.

Page 1 of 1

You might also like